Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2020 07:00 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma To Report First Quarter 2020 Financial Results on May 14, 2020

NEW YORK and VIENNA, Austria, May 04, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and...
April 29, 2020 07:00 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma to Present at Upcoming Conferences in May

NEW YORK and VIENNA, Austria, April 29, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
April 21, 2020 07:00 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma Announces Publication of HB-101 Phase 1 Results in The Journal of Infectious Diseases

NEW YORK and VIENNA, Austria, April 21, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
March 19, 2020 07:00 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update

NEW YORK and VIENNA, Austria, March 19, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
March 10, 2020 08:15 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma To Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 19, 2020

NEW YORK and VIENNA, Austria, March 10, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
February 18, 2020 08:00 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma to Present at SVB Leerink 9th Annual Global Healthcare Conference

NEW YORK and VIENNA, Austria, Feb. 18, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
January 06, 2020 07:00 ET | Source: Hookipa Pharma Inc

HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

NEW YORK and VIENNA, Austria, Jan. 06, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
December 30, 2019 07:30 ET | Source: Hookipa Pharma Inc

HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers

NEW YORK and VIENNA, Austria, Dec. 30, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
November 25, 2019 08:00 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma to Present at Piper Jaffray 31st Annual Healthcare Conference

NEW YORK and VIENNA, Austria, Nov. 25, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...
November 12, 2019 16:01 ET | Source: Hookipa Pharma Inc

HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update

NEW YORK and VIENNA, Austria, Nov. 12, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases...